Tumor FAK orchestrates immunosuppression in ovarian cancer via the CD155/TIGIT axis.

MLA

Duygu Ozmadenci, et al. “Tumor FAK Orchestrates Immunosuppression in Ovarian Cancer via the CD155/TIGIT Axis.” Proceedings of the National Academy of Sciences of the United States of America, vol. 119, no. 17, Apr. 2022, pp. 1–11. EBSCOhost, https://doi.org/10.1073/pnas.2117065119.

APA

Duygu Ozmadenci, Narayanan, J. S. S., Andrew, J., Ojalill, M., Barrie, A. M., Jiang, S., Iyer, S., Xiao Lei Chen, Rose, M., Estrada, V., Molinolo, A., Bertotto, T., Mikulski, Z., McHale, M. C., White, R. R., Connolly, D. C., Pachter, J. A., Kuchroo, V. K., Stupack, D. G., & Schlaepfer, D. D. (2022). Tumor FAK orchestrates immunosuppression in ovarian cancer via the CD155/TIGIT axis. Proceedings of the National Academy of Sciences of the United States of America, 119(17), 1–11. https://doi.org/10.1073/pnas.2117065119

Chicago

Duygu Ozmadenci, Jayanth S. Shankara Narayanan, Jacob Andrew, Marjaana Ojalill, Allison M. Barrie, Shulin Jiang, Samhita Iyer, et al. 2022. “Tumor FAK Orchestrates Immunosuppression in Ovarian Cancer via the CD155/TIGIT Axis.” Proceedings of the National Academy of Sciences of the United States of America 119 (17): 1–11. doi:10.1073/pnas.2117065119.